Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Zileuton trials recommended for new indication: atopic dermatitis

Nov. 27, 1998

Continued positive results with fexofenadine in patients with CIU

Nov. 27, 1998

Organogenesis completes patient enrollment in Apligraf diabetic foot ulcer trial

Nov. 19, 1998

Positive phase III clinical trial results received for Olux

Nov. 12, 1998

Team from Angiotech demonstrates paclitaxel's potential as an antipsoriatic

Nov. 12, 1998

Idec Pharmaceuticals: Q3 1998 highlights

Nov. 4, 1998

AlloDerm used to successfully treat rare congenital condition in newborn

Nov. 3, 1998

Aminoacyl sulfamides synthesized at Cubist claimed for psoriasis

Nov. 2, 1998

ICN obtains rights to Senetek skincare cosmeceutical

Oct. 29, 1998

RU-58841 shows potential as topical agent for alopecia and other skin disorders

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...